ReviewCureus2021

Relapsed/Refractory Non-Hodgkin Lymphoma: Engineering T-Cells to Express Chimeric Antigen Receptors (CARs), a Salvage?

Bushra KanwalPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.